Casey T. Weaver
Corporate Officer/Principal bei The University of Alabama School of Medicine
Profil
Casey T.
Weaver is the founder of Sesen Bio, Inc. (founded in 2008).
Currently, Dr. Weaver is a Professor at The University of Alabama School of Medicine (since 1992).
Previously, Dr. Weaver worked as an Assistant Professor at the University of Washington.
Dr. Weaver received undergraduate and doctorate degrees from the University of Florida.
Aktive Positionen von Casey T. Weaver
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of Alabama School of Medicine | Corporate Officer/Principal | 01.01.1992 |
Ehemalige bekannte Positionen von Casey T. Weaver
| Unternehmen | Position | Ende |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| CARISMA THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Casey T. Weaver
| University of Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |